BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 30572909)

  • 1. Age reprogramming and epigenetic rejuvenation.
    Singh PB; Newman AG
    Epigenetics Chromatin; 2018 Dec; 11(1):73. PubMed ID: 30572909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain.
    López-León M; Outeiro TF; Goya RG
    Ageing Res Rev; 2017 Nov; 40():168-181. PubMed ID: 28903069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconstructing age reprogramming.
    Singh PB; Laktionov PP; Newman AG
    J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejuvenation by Partial Reprogramming of the Epigenome.
    Mendelsohn AR; Larrick JW; Lei JL
    Rejuvenation Res; 2017 Apr; 20(2):146-150. PubMed ID: 28314379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.
    Mishra S; Kacin E; Stamatiadis P; Franck S; Van der Jeught M; Mertes H; Pennings G; De Sutter P; Sermon K; Heindryckx B; Geens M
    Mol Hum Reprod; 2018 Apr; 24(4):173-184. PubMed ID: 29471503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic rejuvenation.
    Manukyan M; Singh PB
    Genes Cells; 2012 May; 17(5):337-43. PubMed ID: 22487104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elixir of Life: Thwarting Aging With Regenerative Reprogramming.
    Beyret E; Martinez Redondo P; Platero Luengo A; Izpisua Belmonte JC
    Circ Res; 2018 Jan; 122(1):128-141. PubMed ID: 29301845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular reprogramming and epigenetic rejuvenation.
    Simpson DJ; Olova NN; Chandra T
    Clin Epigenetics; 2021 Sep; 13(1):170. PubMed ID: 34488874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology.
    Sogabe Y; Seno H; Yamamoto T; Yamada Y
    Cancer Sci; 2018 Sep; 109(9):2641-2650. PubMed ID: 29989289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic Cell Reprogramming Informed by the Oocyte.
    Gonzalez-Munoz E; Cibelli JB
    Stem Cells Dev; 2018 Jul; 27(13):871-887. PubMed ID: 29737235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of cellular rejuvenation.
    Denoth-Lippuner A; Jessberger S
    FEBS Lett; 2019 Dec; 593(23):3381-3392. PubMed ID: 31197818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
    Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
    Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic reprogramming of the germ cell nuclear factor gene is required for proper differentiation of induced pluripotent cells.
    Wang H; Wang X; Xu X; Zwaka TP; Cooney AJ
    Stem Cells; 2013 Dec; 31(12):2659-66. PubMed ID: 23495137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejuvenation of Cardiac Tissue Developed from Reprogrammed Aged Somatic Cells.
    Cheng Z; Peng HL; Zhang R; Fu XM; Zhang GS
    Rejuvenation Res; 2017 Oct; 20(5):389-400. PubMed ID: 28478705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells.
    Ruiz S; Diep D; Gore A; Panopoulos AD; Montserrat N; Plongthongkum N; Kumar S; Fung HL; Giorgetti A; Bilic J; Batchelder EM; Zaehres H; Kan NG; Schöler HR; Mercola M; Zhang K; Izpisua Belmonte JC
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16196-201. PubMed ID: 22991473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in human pluripotent cells due to reprogramming mechanisms.
    Ma H; Morey R; O'Neil RC; He Y; Daughtry B; Schultz MD; Hariharan M; Nery JR; Castanon R; Sabatini K; Thiagarajan RD; Tachibana M; Kang E; Tippner-Hedges R; Ahmed R; Gutierrez NM; Van Dyken C; Polat A; Sugawara A; Sparman M; Gokhale S; Amato P; Wolf DP; Ecker JR; Laurent LC; Mitalipov S
    Nature; 2014 Jul; 511(7508):177-83. PubMed ID: 25008523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Terzic A
    J Cardiovasc Transl Res; 2011 Apr; 4(2):131-7. PubMed ID: 21207217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic rejuvenation by partial reprogramming.
    Puri D; Wagner W
    Bioessays; 2023 Apr; 45(4):e2200208. PubMed ID: 36871150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling.
    Grzybek M; Golonko A; Walczak M; Lisowski P
    Neurobiol Dis; 2017 Mar; 99():84-120. PubMed ID: 27890672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.